![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Gallicchio Vincent S
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.15, Iss.6, 2005-06, pp. : 659-673
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting ribonucleotide reductase for cancer therapy
By Shao Jimin Liu Xiyong Zhu Lijun Yen Yun
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 12, 2013-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)